| Financial Year |
March 31 2023 |
| Monetary Funds |
503,852,768.68 |
| Held-for-trading Financial Assets |
25,664,013.45 |
| Notes Receivable |
-- |
| Accounts Receivable |
31,365,184.51 |
| Advances to Suppliers |
130,612,257.52 |
| Other Receivables |
464,747,657.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,210.00 |
| Inventories |
1,089,564,485.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,399,961.39 |
| Total Current Assets |
2,333,206,328.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
164,720,168.29 |
| Long-term Equity Investment |
282,405,695.12 |
| Investment Properties |
6,778,276,571.60 |
| Fixed Assetes |
3,692,875,881.00 |
| Under-construction Projects |
1,236,540,157.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,620,381,085.30 |
| R&D expenses |
-- |
| Goodwill |
1,173,607,911.25 |
| Long-Term Deferred and Prepaid Expenses |
366,417,287.94 |
| Deferred Income Tax Assets |
165,709,455.62 |
| Other Non-Current Assets |
333,021,195.24 |
| Sub-Total of Non-Current Assets |
17,830,402,465.82 |
| Total Assets |
20,163,608,794.78 |
| Short-Term Loans |
910,934,332.58 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,348,908,400.85 |
| Accounts Received In Advance |
30,544,937.28 |
| Employee Compensation Payable |
23,777,965.83 |
| Taxes Payable |
294,656,869.88 |
| Interest Payable |
-- |
| Dividend Payable |
26,051,278.82 |
| Other payables |
887,532,311.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,496,449,080.67 |
| Other Current Liabilities |
93,664,939.65 |
| Sub-Total of Current Liabilities |
5,829,455,320.22 |
| Long-term Loans |
3,102,155,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,588,020.30 |
| Deferred Income Tax Liabilities |
1,959,248,380.33 |
| Other Non-Current Liabilities |
11,510,230.25 |
| Sub-Total of Non-Current Liabilities |
6,509,939,226.80 |
| Total Liabilities |
12,339,394,547.02 |
| Paid-In Capital(Or Share Stock) |
1,731,982,546.00 |
| Capital Surplus |
-23,427,649.15 |
| Surplus Reserve |
180,794,604.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,764,227,102.11 |
| Minority Stockholder's Interest |
547,429,227.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,276,785,020.34 |
| Owner's Equity（Stockholder's Equity） |
7,824,214,247.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,163,608,794.78 |
